期刊文献+

链霉亲和素化载紫杉醇相变型PLGA纳米粒的制备及体外超声显影 被引量:5

Preparation of streptavidin-coated and paclitaxel-loaded phase-shifting PLGA nanoparticles and ultrasound imaging in vitro
下载PDF
导出
摘要 目的制备链霉亲和素化载紫杉醇相变型PLGA纳米粒(PTX-PLGA-SA/PFPs),并观察其体外低强度聚焦超声(LIFU)致相变后超声增强显影特性。方法采用单乳化法(O/W)制备载紫杉醇相变型PLGA纳米粒,高效液相色谱法检测紫杉醇包封率;碳二亚胺法连接链霉亲和素(SA),共聚焦激光显微镜观察二者连接情况,流式细胞术检测二者链接率;体外LIFU致相变观察超声增强显影情况。结果制备的纳米粒粒径为(322.2±85.6)nm,表面电位(-5.66±3.46)mV。紫杉醇的包封率及载药量分别为(71.56±6.51)%、(6.57±0.61)%,与链霉亲和素的连接率为(97.16±1.20)%。LIFU功率7.5 W作用3min时可明显增强该纳米粒在体外的B-mode及造影模式下的超声显影。结论成功制备了PTX-PLGA-SA/PFPs纳米粒,其紫杉醇包封率高、链霉亲和素连接率高,体外声致相变后可显著增强超声显影。 Objective To prepare a paclitaxel-loaded and streptavidin-coated phase-shifting PLGA nanoparticle as an agents for tumor ultrasound molecular imaging and treatment, and to explore the condition of low intensity focused ultra- sound (LIFU) inducing phase transition of the nanoparticles to enhance the ultrasound imaging. Methods The single emulsion method (O/W) was used to prepare the paclitaxel-loaded nanoparticles (NBs). The NBs size and zeta potential were detected by Melvin size analyzer. The streptavidin (SA) was covalently linked on the NBs through carbodiimide meth- od, and the connection rate was detected by flow cytometry (FCM). The encapsulation efficiency of paclitaxel capsuled in NBs was determined by high-performance liquid chromatography (HPLC). Different intensities of LIFU were applied to optimize the condition of phase transition of NBs. Results The size of NBs was (322.2±85.6)nm, and zeta potential was (-5.66±3.46)mV. The SA was successfully conjugated to the NBs, and the connection rate was (97.16±1.20)%. The encapsulation efficiency and drug loading efficiency of paclitaxel were (71.56±6.51) % and (6.5±0.61)%, respectively. When the the LIFU powers was 7.5 W working for 3 min, the NBs occurring phase transition could significantly enhance the ultrasound imaging in both B-mode and contrast enhance mode. Conclusion The paclitaxel-loaded and streptavidin-coated phase-shifting PLGA nanopartide is successfully prepared. With high encapsulation efficiency of paclitaxel and high connection rate of SA, the NBs can be used to significantly enhance ultrasound imaging in vitro after phase transition triggered by LIFU.
出处 《中国介入影像与治疗学》 CSCD 北大核心 2016年第9期571-575,共5页 Chinese Journal of Interventional Imaging and Therapy
基金 国家临床重点专科建设项目(国卫医办函[2013]544号)
关键词 超声检查 造影剂 紫杉醇 液气相变 链霉亲和素 Ultrasonography Contrast media Paclitaxel Phase-shift Streptavidin
  • 相关文献

参考文献16

  • 1Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: Role of tumor type and mieroenviron- ment. Proc NatlAcad SciUSA, 1998,95(8):4607-4612.
  • 2Sheeran PS, Daghighi Y, Yoo K, et al. Image-guided ultrasound characterization of volatile sub-micron phase-shift droplets in the 20-40 MHz frequency range. Ultrasound Med Biol, 2016,42(3): 795-807.
  • 3何坤燕,冉海涛,李茂萍,郑元义,王志刚.包裹液态氟碳高分子纳米球相变及体外超声显影[J].中国介入影像与治疗学,2013,10(11):679-683. 被引量:7
  • 4Niu C, Wang Z, Lu G, et al. Doxorubicin loaded superparamag- netie PLGA-iron oxide multifunctional microhubbles for dual- mode US/MR imaging and therapy of metastasis in lymph nodes. Biomaterials, 2013,34(9) : 2307-23]7.
  • 5Esfandyari-Manesh M, Mostafavi SH, Majidi RF, et al. Im- proved antieancer delivery of paclitaxel by albumin surface modifi- cation of PLGA nanoparticles. Daru, 2015,23 ( 1 ) : 28.
  • 6Deng L, Li L, Yang H, et al. Development and optimization of doxoruhicin loaded poly (lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells. J Nanosci Nanotechnol, 2014, 14 (4) : 2947-2954.
  • 7Anderson i'M, Shire MS. Biodegradation and bioeompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 2012, 64 (S) : 72-82.
  • 8Shi YL, Zhou MY, Zhang J, et al. Preparation and cellular tar- geting study o{ VEGF-conjugated PLGA nanoparticles. J Micro- ertcapsul, 2015,32(7) :699-704.
  • 9Kocbek P, Obermajer N, Cegnar M, et al. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal anti- body. J Control Release, 2007, 120(1-2) :18-26.
  • 10许乙凯,刘岘,叶靖.二步法预定位技术对荷人肝癌裸鼠模型的MR免疫成像研究[J].中华放射学杂志,2005,39(4):357-361. 被引量:6

二级参考文献55

  • 1Boerman OC, van Schaijk FG, Oyen WJ, et al. Pretargeted radioimmunotherapy of cancer: progress step by step(Review). J Nucl Med, 2003, 44: 400-411.
  • 2Weinmann HJ, Ebert W, Misselwitz B, et al. Tissue-specific MR contrast agents(Review). Eur J Radiol, 2003, 46: 33-44.
  • 3He J, Liu G, Gupta S, et al. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept. J Nucl Med, 2004, 45:1087-1095.
  • 4Saccavini JC, Curtet C, Bohy J, et al. Magnetic resonance imaging studies on nude mice grafted with colorectal adenocarcinoma using gadolinium-labeled monoclonal antibody. Invest Radiol, 1988, 23 (Suppl 1): S292-S293.
  • 5Lue RY, Chen GY, Zhu Q, et al. Site-specific immobilization of biotinylated proteins for protein microarray analysis. Methods Mol Biol,2004, 264:85-100.
  • 6Nordlund HR, Laitinen OH, Hytonen VP, et al. Construction of a dual chain pseudotetrameric chicken avidin by combining two circularly permuted avidins. J Biol Chem,2004, 279: 36715-36719.
  • 7Lazaridis T, Masunov A, Gandolfo F. Contributions to the binding free energy of ligands to avidin and streptavidin. Proteins, 2002, 47:194-208.
  • 8Chmura AJ, Orton MS, Meares CF. Antibodies with infinite affinity. Proc Natl Acad Sci USA, 2001, 98:8480-8484.
  • 9Topp EM, Kitos PA, Vijaykumar V, et al. Antibody transport in cultured tumor cell layers(Review). J Control Release, 1998, 53:15-23.
  • 10Geninatti Crich S, Barge A, Battistini E, et al. Magnetic resonance imaging visualization of targeted cells by the internalization of supramolecular adducts formed between avidin and biotinylated Gd(3+) chelates. J Biol Inorg Chem, 2005, 10: 78-86.

共引文献16

同被引文献13

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部